{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T18:18:44Z","timestamp":1778609924926,"version":"3.51.4"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100011512","name":"National Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011512","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.jsbmb.2019.04.018","type":"journal-article","created":{"date-parts":[[2019,4,27]],"date-time":"2019-04-27T20:05:24Z","timestamp":1556395524000},"page":"105369","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["11\u03b1-Hydroxyprogesterone, a potent 11\u03b2-hydroxysteroid dehydrogenase inhibitor, is metabolised by steroid-5\u03b1-reductase and cytochrome P450 17\u03b1-hydroxylase\/17,20-lyase to produce C11\u03b1-derivatives of 21-deoxycortisol and 11-hydroxyandrostenedione in vitro"],"prefix":"10.1016","volume":"191","author":[{"given":"Rachelle","family":"Gent","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Therina","family":"du Toit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda C.","family":"Swart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsbmb.2019.04.018_bib0005","doi-asserted-by":"crossref","first-page":"13228","DOI":"10.3390\/molecules181113228","article-title":"11\u03b2-hydroxyandrostenedione returns to the steroid arena: biosynthesis, metabolism and function","volume":"18","author":"Bloem","year":"2013","journal-title":"Molecules"},{"key":"10.1016\/j.jsbmb.2019.04.018_bib0010","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jsbmb.2017.12.014","article-title":"The in vitro metabolism of 11\u03b2-hydroxyprogesterone and 11-ketoprogesterone to 11-ketodihydrotestosterone in the backdoor pathway","volume":"178","author":"van Rooyen","year":"2018","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2019.04.018_bib0015","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jsbmb.2017.07.034","article-title":"Adrenal C11-oxy C21steroids contribute to the C11-oxy C19 steroid pool via the backdoor pathway in the biosynthesis and metabolism of 21-deoxycortisol and 21-deoxycortisone","volume":"174","author":"Barnard","year":"2017","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2019.04.018_bib0020","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1677\/joe.1.06019","article-title":"11\u03b2-Hydroxysteroid dehydrogenase and the pre-receptor regulation of corticosteroid hormone action","volume":"186","author":"Draper","year":"2005","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.jsbmb.2019.04.018_bib0025","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.tem.2004.09.007","article-title":"11\u03b2-hydroxysteroid dehydrogenase type 1 as a modulator of glucocorticoid action: From metabolism to memory","volume":"15","author":"Seckl","year":"2004","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2019.04.018_bib0030","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1210\/jc.2006-2325","article-title":"Inhibition of 11\u03b2-hydroxysteroid dehydrogenase type 1 activity in vivo limits glucocorticoid exposure to human adipose tissue and decreased lipolysis","volume":"92","author":"Tomlinson","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2019.04.018_bib0035","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1210\/endo.137.6.8641180","article-title":"11 beta-Hydroxysteroid dehydrogenase type 2 complementary deoxyribonucleic acid stably transfected into Chinese hamster ovary cells: specific inhibition by 11 alpha-hydroxyprogesterone","volume":"137","author":"Morita","year":"1996","journal-title":"Endocrinology"},{"key":"10.1016\/j.jsbmb.2019.04.018_bib0040","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1210\/endo.136.4.7895695","article-title":"11\u03b1- and 11\u03b2-hydroxyprogesterone, potent inhibitors of 11\u03b2-hydroxysteroid dehydrogenase (isoforms 1 and 2), confer marked mineralocorticoid activity on corticosterone in the ADX rat","volume":"136","author":"Souness","year":"1995","journal-title":"Endocrinology"},{"key":"10.1016\/j.jsbmb.2019.04.018_bib0045","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jsbmb.2019.02.013","article-title":"The 11\u03b2-hydroxysteroid dehydroganse isoforms: pivotal catalytic activities yield potent C11-oxy C19 steroids with 11\u03b2HSD2 favouring 11-ketotestosterone, 11-ketoandrostenedione and 11-ketoprogesterone biosynthesis","volume":"189","author":"Gent","year":"2019","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2019.04.018_bib0050","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.cca.2015.06.008","article-title":"Detection of urine metabolites in polycystic ovary syndrome by UPLC triple-TOF-MS","volume":"448","author":"Wang","year":"2015","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.jsbmb.2019.04.018_bib0055","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.jsbmb.2015.07.024","article-title":"Estimation of reference curves for the urinary steroid metabolome in the first year of life in healthy children: tracing the complexity of human postnatal steroidogenesis","volume":"154","author":"Dhayat","year":"2015","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2019.04.018_bib0060","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1210\/er.2003-0030","article-title":"Overview of steroidogenic enzymes in the pathway from cholesterol to active steroid hormones","volume":"25","author":"Payne","year":"2004","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.jsbmb.2019.04.018_bib0065","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3181\/00379727-82-20080","article-title":"Anti-gonadal hormone activity of II\u03b1-hydroxyprogesterone","volume":"82","author":"Byrnes","year":"1953","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.jsbmb.2019.04.018_bib0070","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1365-2133.1982.tb00291.x","article-title":"The effect of the antiandrogen II\u03b1-hydroxyprogesterone on sebum production and cholesterol concentration of sebum","volume":"107","author":"Tamm","year":"1982","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jsbmb.2019.04.018_bib0075","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s004030050328","article-title":"Inhibition of skin 11\u03b2-hydroxysteroid dehydrogenase activity in vivo potentiates the anti-inflammatory actions of glucocorticoids","volume":"290","author":"Hennebold","year":"1998","journal-title":"Arch. Dermatol. Res."},{"key":"10.1016\/j.jsbmb.2019.04.018_bib0080","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1530\/eje.0.1460789","article-title":"Agonistic and antagonistic properties of progesterone metabolites at the human mineralocorticoid receptor","volume":"146","author":"Quinkler","year":"2002","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.jsbmb.2019.04.018_bib0085","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0960-0760(95)00120-O","article-title":"Specific interactions of progestins and anti-progestins with progesterone antibodies, plasma binding proteins and the human recombinant receptor","volume":"54","author":"Mais","year":"1995","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2019.04.018_bib0090","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.mce.2017.09.026","article-title":"Inefficient UGT-conjugation of adrenal 11\u03b2-hydroxyandrostenedione metabolites highlights C11-oxy C19 steroids as the predominant androgens in prostate cancer","volume":"461","author":"du Toit","year":"2018","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.jsbmb.2019.04.018_bib0095","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.mce.2013.07.006","article-title":"11\u03b2-Hydroxydihydrotestosterone and 11-ketodihydrotestosterone, novel C19 steroids with androgenic activity: a putative role in castration resistant prostate cancer?","volume":"377","author":"Storbeck","year":"2013","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.jsbmb.2019.04.018_bib0100","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jchromb.2018.02.023","article-title":"A high-throughput UPC2-MS\/MS method for the separation and quantification of C19and C21 steroids and their C11-oxy steroid metabolites in the classical, alternative, backdoor and 11OHA4 steroid pathways","volume":"1080","author":"du Toit","year":"2018","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jsbmb.2019.04.018_bib0105","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.febslet.2004.06.065","article-title":"Hexose-6-phosphate dehydrogenase determines the reaction direction of 11\u00df-hydroxysteroid dehydrogenase type 1 as an oxoreductase","volume":"571","author":"Atanasov","year":"2004","journal-title":"FEBS Lett."},{"key":"10.1016\/j.jsbmb.2019.04.018_bib0110","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.bbagen.2013.10.006","article-title":"Differential response of DU145 and PC3 prostate cancer cells to ionizing radiation: role of reactive oxygen species, GSH and Nrf2 in radiosensitivity","volume":"1840","author":"Jayakumar","year":"2014","journal-title":"Biochim. Biophys. Acta \u2013 Gen. Subj."},{"key":"10.1016\/j.jsbmb.2019.04.018_bib0115","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.beem.2008.01.008","article-title":"Androgen biosynthetic pathways in the human prostate","volume":"22","author":"Luu-The","year":"2008","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2019.04.018_bib0120","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1210\/jc.2015-1023","article-title":"Profiles of 21-carbon steroids in 21-hydroxylase deficiency","volume":"100","author":"Turcu","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2019.04.018_bib0125","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1210\/jc.2012-2912","article-title":"Liquid chromatography-tandem mass spectrometry analysis of human adrenal vein 19-carbon steroids before and after ACTH stimulation","volume":"98","author":"Rege","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2019.04.018_bib0130","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jsbmb.2017.12.016","article-title":"Androgen excess is due to elevated 11-oxygenated androgens in treated children with congenital adrenal hyperplasia","volume":"178","author":"Kamrath","year":"2018","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2019.04.018_bib0135","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.jsbmb.2016.08.006","article-title":"The urinary steroidome of treated children with classic 21-hydroxylase deficiency","volume":"165","author":"Kamrath","year":"2017","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2019.04.018_bib0140","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jsbmb.2015.04.009","article-title":"Advances in the analytical methodologies: profiling steroids in familiar pathways-challenging dogmas","volume":"153","author":"Bloem","year":"2015","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2019.04.018_bib0145","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jchromb.2016.07.024","article-title":"High-throughput analysis of 19 endogenous androgenic steroids by ultra-performance convergence chromatography tandem mass spectrometry","volume":"1031","author":"Quanson","year":"2016","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jsbmb.2019.04.018_bib0150","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jsbmb.2016.06.009","article-title":"Profiling adrenal 11\u03b2-hydroxyandrostenedione metabolites in prostate cancer cells, tissue and plasma: UPC2-MS\/MS quantification of 11\u03b2-hydroxytestosterone, 11keto-hydroxytestosterone and 11keto-dihydrotestosterone","volume":"166","author":"du Toit","year":"2016","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2019.04.018_bib0155","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.mce.2005.08.006","article-title":"Endogenous selective inhibitors of 11beta-hydroxysteroid dehydrogenase isoforms 1 and 2 ofadrenal origin","volume":"243","author":"Latif","year":"2005","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.jsbmb.2019.04.018_bib0160","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0039-128X(96)00163-8","article-title":"Human 11\u03b2-hydroxysteroid dehydrogenase: studies on the stably transfected isoforms and localization of the type 2 isozyme within renal tissue","volume":"62","author":"Bujalska","year":"1997","journal-title":"Steroids"},{"key":"10.1016\/j.jsbmb.2019.04.018_bib0165","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jsbmb.2013.04.010","article-title":"11\u03b2-hydroxyandrostenedione, the product of androstenedione metabolism in the adrenal, is metabolized in LNCaP cells by 5\u03b1-reductase yielding 11\u03b2-hydroxy-5\u03b1-androstanedione","volume":"138","author":"Swart","year":"2013","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2019.04.018_bib0170","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jsbmb.2016.07.009","article-title":"Androgen biosynthesis during minipuberty favors the backdoor pathway over the classic pathway: insights into enzyme activities and steroid fluxes in healthy infants during the first year of life from the urinary steroid metabolome","volume":"165","author":"Dhayat","year":"2017","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2019.04.018_bib0175","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.clinbiochem.2014.07.017","article-title":"A guide to understanding the steroid pathway: new insights and diagnostic implications","volume":"47","author":"Greaves","year":"2014","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.jsbmb.2019.04.018_bib0180","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.tem.2017.09.002","article-title":"Steroidogenesis: unanswered questions","volume":"28","author":"Miller","year":"2017","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2019.04.018_bib0185","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0960-0760(92)90011-7","article-title":"The role of cytochrome b5 in adrenal microsomal steroidogenesis","volume":"42","author":"Kominami","year":"1992","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2019.04.018_bib0190","first-page":"1","article-title":"The rise, fall, and resurrection of 11-oxygenated androgens in human physiology and disease","volume":"9","author":"Turcu","year":"2018","journal-title":"Horm. Res. Paediatr."},{"key":"10.1016\/j.jsbmb.2019.04.018_bib0195","first-page":"2304","article-title":"Differential activity of the cytochrome P450 17\u03b1-Hydroxylase and steroidogenic acute regulatory protein gene promoters in normal and polycystic ovary syndrome theca cells","volume":"85","author":"Wickenheisser","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2019.04.018_bib0200","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1210\/mend.13.6.0311","article-title":"Augmented androgen production is a stable steroidogenic phenotype of propagated theca cells from polycystic ovaries","volume":"13","author":"Nelson","year":"2014","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.jsbmb.2019.04.018_bib0205","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.mce.2016.07.029","article-title":"Genes and proteins of the alternative steroid backdoor pathway for dihydrotestosterone synthesis are expressed in the human ovary and seem enhanced in the polycystic ovary syndrome","volume":"441","author":"Marti","year":"2017","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.jsbmb.2019.04.018_bib0210","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.tem.2004.09.004","article-title":"The backdoor pathway to dihydrotestosterone","volume":"15","author":"Auchus","year":"2004","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2019.04.018_bib0215","first-page":"212","article-title":"Steroid hormone synthetic pathways in prostate cancer","volume":"2","author":"Mostaghel","year":"2013","journal-title":"Transl. Androl. Urol."},{"key":"10.1016\/j.jsbmb.2019.04.018_bib0220","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.mce.2014.12.009","article-title":"11\u03b2-hydroxyandrostenedione: downstream metabolism by 11\u03b2HSD, 17\u03b2HSD and SRD5A produces novel substrates in familiar pathways","volume":"408","author":"Swart","year":"2015","journal-title":"Mol. Cell. Endocrinol."}],"container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076019301037?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076019301037?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T00:03:38Z","timestamp":1760745818000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960076019301037"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":44,"alternative-id":["S0960076019301037"],"URL":"https:\/\/doi.org\/10.1016\/j.jsbmb.2019.04.018","relation":{},"ISSN":["0960-0760"],"issn-type":[{"value":"0960-0760","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"11\u03b1-Hydroxyprogesterone, a potent 11\u03b2-hydroxysteroid dehydrogenase inhibitor, is metabolised by steroid-5\u03b1-reductase and cytochrome P450 17\u03b1-hydroxylase\/17,20-lyase to produce C11\u03b1-derivatives of 21-deoxycortisol and 11-hydroxyandrostenedione in vitro","name":"articletitle","label":"Article Title"},{"value":"The Journal of Steroid Biochemistry and Molecular Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsbmb.2019.04.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105369"}}